Affiliation:
1. Department of Clinical Oncology, A.C.Camargo Cancer Center, Sao Paulo, Brazil
2. Grupo Oncoclinicas, Florianopolis, Brazil
3. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
Abstract
Neuroendocrine neoplasms (NENs) comprise a beautifully complicated, exciting landscape of histologies and clinical behaviors. However, the nuanced complexity of low- and high-grade variants can easily overwhelm both patients and providers. In this chapter, we review the ever-expanding literature on both functioning and nonfunctioning small bowel and pancreatic NENs, touching on somatostatin analogs, hepatic-directed therapies, small molecules, radiopharmaceuticals, immunotherapy, cytotoxic chemotherapy, and new promising agents. Furthermore, we suggest some strategies to address the most challenging scenarios seen in clinical practice, including sequencing of agents, treatment of carcinoid syndrome, and options for well-differentiated high-grade disease.
Publisher
American Society of Clinical Oncology (ASCO)